{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:42:21Z","timestamp":1756460541928},"reference-count":17,"publisher":"Hindawi Limited","issue":"2","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.emerald.com\/insight\/site-policies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MIJ"],"published-print":{"date-parts":[[2019,11,4]]},"abstract":"<jats:sec>\n<jats:title content-type=\"abstract-subheading\">Purpose<\/jats:title>\n<jats:p>Since the development of antipsychotic drugs in the 1950s, a variety of studies and case reports have been published that suggest an association between exposure to typical antipsychotics and venous thromboembolisms (VTE). Therefore, when starting treatment with antipsychotics, especially low-potency typical antipsychotics and clozapine, health-care providers must account for the patient\u2019s existing VTE risk factors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title content-type=\"abstract-subheading\">Design\/methodology\/approach<\/jats:title>\n<jats:p>In this case report, the authors describe the development of a pulmonary embolism associated with use of chlorpromazine in the treatment of an acute manic episode in a 51-year-old female patient with bipolar disorder type 1.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title content-type=\"abstract-subheading\">Findings<\/jats:title>\n<jats:p>The patient was brought to the emergency room by the police on a legal hold for bizarre behaviors at a bus stop, which included incessantly yelling at bystanders. The patient was found to have disorganized thoughts, poor sleep, rapid speech, labile mood, distractibility, auditory hallucinations and grandiose delusions. During the course of her stay, the patient received extensive IM chlorpromazine for extreme agitation, in addition to chlorpromazine 200\u2009mg IM Q8H, which was later decreased to chlorpromazine 100\u2009mg chlorpromazine IM\/PO Q8H. On day 4 of the treatment, the patient experienced difficulty breathing, hypoxia and tachycardia and was found to have bilateral expiratory wheezes. CT angiography showed sub-segmental pulmonary embolus and the patient was transferred to MICU service. The patient was then intubated and started on heparin by the medical team. Over the course of the next day, her respiratory distress resolved and the patient was extubated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title content-type=\"abstract-subheading\">Originality\/value<\/jats:title>\n<jats:p>It is possible that chlorpromazine may indeed increase VTEs, and there are various physiological postulations regarding the mechanism of action. However, multiple confounding variables existed in the authors\u2019 report, including venous stasis and the use of restraints, tobacco and valproic acid. Each of these variables has been shown to increase VTE occurrence. Further controlled studies are necessary to identify the true relationship between antipsychotics and VTEs.<\/jats:p>\n<\/jats:sec>","DOI":"10.1108\/mij-10-2019-0005","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T14:54:46Z","timestamp":1574952886000},"page":"16-19","source":"Crossref","is-referenced-by-count":5,"title":["Case report: Chlorpromazine and deep venous thrombosis"],"prefix":"10.1155","volume":"11","author":[{"given":"Matthew Joseph","family":"Reed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Comeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd R.","family":"Wojtanowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat Reddy","family":"Sampathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Penev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Bota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"issue":"8","key":"key2019120611235378600_ref001","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-3223(90)90467-G","article-title":"Neuroleptic-associated autoantibodies. A prevalence study","volume":"27","year":"1990","journal-title":"Biological Psychiatry"},{"issue":"8","key":"key2019120611235378600_ref002","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1742-1241.2010.02380.x","article-title":"The prevention of deep venous thrombosis in physically restrained patients with schizophrenia","volume":"64","year":"2010","journal-title":"International Journal of Clinical Practice"},{"issue":"1","key":"key2019120611235378600_ref003","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.psychres.2008.05.011","article-title":"Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication","volume":"169","year":"2009","journal-title":"Psychiatry Research"},{"issue":"12","key":"key2019120611235378600_ref004","first-page":"702","article-title":"Thrombophilic diatheses as hemostasis disorders in acute psychoses]","volume":"36","year":"1984","journal-title":"Psychiatr Neurol Med Psychol (Leipz)"},{"issue":"8","key":"key2019120611235378600_ref005","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1176\/ajp.143.8.993","article-title":"Prevalence of smoking among psychiatric outpatients","volume":"143","year":"1986","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"key2019120611235378600_ref006","article-title":"Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release","volume":"1052","year":"2005","journal-title":"Brain Research"},{"issue":"3","key":"key2019120611235378600_ref007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4088\/JCP.v62n0312d","article-title":"Physical restraints, thromboembolism, and death in 2 patients","volume":"62","year":"2001","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"7","key":"key2019120611235378600_ref008","article-title":"Risk of venous thromboembolism during treatment with antipsychotic agents","volume":"66","year":"2012","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"5","key":"key2019120611235378600_ref009","article-title":"The ralationship between changes in 5\u2010HT induced platelet aggregation and clinical state in patients treated with fluphenazine","volume":"3","year":"1976","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"8","key":"key2019120611235378600_ref010","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/pds.841","article-title":"Psychotropic drugs and fatal pulmonary embolism","volume":"12","year":"2003","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"2","key":"key2019120611235378600_ref011","first-page":"205","article-title":"Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism","volume":"88","year":"2002","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"key2019120611235378600_ref012","article-title":"Left pulmonary artery thrombosis in chlorpromazine-induced lupus","volume":"98","year":"1990","journal-title":"Chest"},{"issue":"6","key":"key2019120611235378600_ref013","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00001648-199711000-00014","article-title":"Mortality in current and former users of clozapine","volume":"8","year":"1997","journal-title":"Epidemiology"},{"issue":"9237","key":"key2019120611235378600_ref014","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(00)02784-7","article-title":"Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study","volume":"356","year":"2000","journal-title":"The Lancet"},{"issue":"2","key":"key2019120611235378600_ref015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00002018-200629020-00001","article-title":"Interactions between antiepileptic and antipsychotic drugs","volume":"29","year":"2006","journal-title":"Drug Safety"},{"issue":"7","key":"key2019120611235378600_ref016","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1528-1167.2006.00587.x","article-title":"Valproate-associated coagulopathies are frequent and variable in children","volume":"47","year":"2006","journal-title":"Epilepsia"},{"issue":"5","key":"key2019120611235378600_ref017","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1160\/TH05-05-0313","article-title":"Homocysteine and thrombosis: from basic science to clinical evidence","volume":"94","year":"2005","journal-title":"Thromb Haemost"}],"container-title":["Mental Illness"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.emerald.com\/insight\/content\/doi\/10.1108\/MIJ-10-2019-0005\/full\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.emerald.com\/insight\/content\/doi\/10.1108\/MIJ-10-2019-0005\/full\/html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T14:59:26Z","timestamp":1658329166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.emerald.com\/insight\/content\/doi\/10.1108\/MIJ-10-2019-0005\/full\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,11,4]]}},"alternative-id":["10.1108\/MIJ-10-2019-0005"],"URL":"https:\/\/doi.org\/10.1108\/mij-10-2019-0005","relation":{},"ISSN":["2036-7465","2036-7465"],"issn-type":[{"value":"2036-7465","type":"print"},{"value":"2036-7465","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,4]]}}}